|Bid||133.33 x 100|
|Day's Range||134.55 - 136.62|
|52 Week Range||95.14 - 137.00|
|PE Ratio (TTM)||115.16|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Abiomed Inc. (ABMD), a leading developer, manufacturer and marketer of medical products, reported fourth-quarter fiscal 2017 earnings of 33 cents per share, which were in line with the Zacks Consensus Estimate.
Q4 2017 Abiomed Inc Earnings Call
Abiomed posted a promising fourth quarter of fiscal 2017, with revenues beating the Zacks Consensus Estimate and earnings meeting the mark.